Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$50,775,837
in 5 filings, $50.8M under 10b5-1 plans

Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-05-11 Bancel Stephane Chief Executive Officer Sale 10b5-1 −4,470 $127.92 $572K 5,412,146
2023-05-11 Bancel Stephane Chief Executive Officer Sale 10b5-1 −200 $128.84 $26K 5,411,946
2023-05-11 Bancel Stephane Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −40,000 507,155
2023-05-10 Bancel Stephane Chief Executive Officer Exercise or conversion 10b5-1 +40,000 $0.99 $40K 5,451,946
2023-05-10 Bancel Stephane Chief Executive Officer Sale 10b5-1 −16,954 $131.08 $2.2M 5,434,992
2023-05-10 Bancel Stephane Chief Executive Officer Sale 10b5-1 −21,247 $131.89 $2.8M 5,413,745
2023-05-10 Bancel Stephane Chief Executive Officer Sale 10b5-1 −1,499 $132.97 $199K 5,412,246
2023-05-10 Bancel Stephane Chief Executive Officer Sale 10b5-1 −300 $133.71 $40K 5,411,946
2023-05-10 Bancel Stephane Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −40,000 547,155
2023-05-10 Hoge Stephen President Sale 10b5-1 −250 $133.37 $33K 1,630,732
2023-05-09 Hoge Stephen President Exercise or conversion 10b5-1 +522 1,630,982
2023-05-09 Hoge Stephen President Exercise or conversion · Restricted Stock Units 10b5-1 −522 3,657
2023-05-04 Bancel Stephane Chief Executive Officer Exercise or conversion 10b5-1 +40,000 $0.99 $40K 5,451,946
2023-05-04 Bancel Stephane Chief Executive Officer Sale 10b5-1 −600 $132.98 $80K 5,451,346
2023-05-04 Bancel Stephane Chief Executive Officer Sale 10b5-1 −2,846 $134.32 $382K 5,448,500
2023-05-04 Bancel Stephane Chief Executive Officer Sale 10b5-1 −13,468 $135.06 $1.8M 5,435,032
2023-05-04 Bancel Stephane Chief Executive Officer Sale 10b5-1 −16,552 $136.01 $2.3M 5,418,480
2023-05-04 Bancel Stephane Chief Executive Officer Sale 10b5-1 −5,427 $136.97 $743K 5,413,053
2023-05-04 Bancel Stephane Chief Executive Officer Sale 10b5-1 −1,107 $137.76 $153K 5,411,946
2023-05-04 Bancel Stephane Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −40,000 587,155

Page 47 of 66 · 1,314 trades